Australia Single-Use Bioreactors Market (2026-2031)
The Australia Single-Use Bioreactors Market was valued at $22.4 Million in 2026 and projected to reach to $33.4 Million by 2031, representing a compound annual growth rate of 8.3%. Australia's single-use bioreactors market is positioned for steady growth as local biopharmaceutical manufacturers and CMOs recognize the operational and financial benefits of single-use technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Single-Use Bioreactors Market Trends and Insights
- Australia is experiencing steady adoption of single-use bioreactor technologies driven by increasing demand from biopharmaceutical manufacturers and contract manufacturing organizations (CMOs) seeking flexible, cost-effective production solutions.
- The market in Australia reflects broader Asia Pacific trends, with local biotech firms and multinational pharmaceutical companies investing in single-use systems to reduce capital expenditure and accelerate time-to-market for biologics. Australia's regulatory environment and established life sciences infrastructure position the country as a growing hub for biopharmaceutical innovation within the region.
- The forecast period (2026-2031) anticipates continued market expansion as Australia's healthcare sector prioritizes advanced manufacturing technologies and process efficiency.
- Single-use bioreactors in Australia are increasingly adopted across vaccine production, monoclonal antibody manufacturing, and cell therapy applications, supporting both domestic demand and regional supply chain resilience..
Key Market Statistics
- CAGR (2026-2031) 8.3% CAGR
- Market Size, 2026 ~USD 22.4 Million
- Forecast, 2031 ~USD 33.4 Million
- Country Australia
Australia Single-Use Bioreactors Market Overview
Market Valuation Growth :
Australia's single-use bioreactors market is valued at USD 22.4 million in 2026 and is projected to reach USD 33.4 million by 2031, demonstrating robust expansion in the region.
Steady CAGR Performance :
The Australian market is growing at a CAGR of 8.3% from 2026 to 2031, reflecting consistent adoption of single-use bioreactor technologies across the biopharmaceutical sector.
CMO and Biopharm Demand :
Increasing demand from Australian biopharmaceutical manufacturers and contract manufacturing organizations (CMOs) is driving adoption of flexible, cost-effective single-use bioreactor solutions.
Technology Adoption Trend :
Australian healthcare and biotech companies are increasingly transitioning to single-use bioreactor systems to reduce capital expenditure, improve operational flexibility, and accelerate time-to-market for biologics.
Australia Single-Use Bioreactors Market Dynamics
- The shift toward flexible manufacturing solutions is particularly relevant for Australian companies seeking to reduce infrastructure costs and improve production scalability.
- With a CAGR of 8.3%, the market reflects growing confidence in single-use systems for both small-scale research and commercial-scale biopharmaceutical production. The Australian market is expected to benefit from increased investment in biotechnology infrastructure, rising demand for personalized medicines, and the expansion of contract manufacturing capabilities.
- As regulatory frameworks continue to support single-use bioreactor adoption and supply chain resilience becomes a priority, Australian organizations are likely to accelerate their transition from traditional stainless-steel systems to single-use alternatives, supporting sustained market expansion through 2031..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Australia's single-use bioreactors market is valued at USD 22.4 million in 2026 and will reach USD 33.4 million by 2031, growing at 8.3% CAGR.
- Australia's biopharmaceutical sector is driving adoption of single-use systems to reduce manufacturing costs and improve operational flexibility.
- Australia's established regulatory framework and life sciences infrastructure support accelerated market growth and regional competitiveness.
- Australia's market expansion is fueled by increasing applications in vaccine production, monoclonal antibodies, and cell therapy manufacturing.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
Australia Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : Australian biotech and pharma companies need market data to evaluate single-use bioreactor investments, assess competitive positioning, and plan manufacturing capacity expansion.
- Contract Manufacturing Organizations (CMOs) : Australian and international CMOs operating in Australia require market insights to justify capital investments in single-use technologies and optimize service offerings for local clients.
- Equipment Suppliers and Vendors : Bioreactor manufacturers and suppliers need Australia-specific market intelligence to identify growth opportunities, develop localized product strategies, and prioritize regional expansion.
- Investment and Private Equity Firms : Investors evaluating opportunities in Australian biotech and manufacturing sectors need market data to assess growth potential, valuation benchmarks, and sector attractiveness.
- Regulatory and Consulting Bodies : Australian regulatory agencies, consultants, and industry associations require market data to inform policy development, industry guidance, and strategic planning initiatives.
Reasons to Buy this Report
- Australia-Specific Market Sizing : Obtain precise valuation data for Australia's single-use bioreactors market (USD 22.4M in 2026, USD 33.4M in 2031) to benchmark investments and competitive positioning within the region.
- Regional Growth Trajectory Insights : Understand Australia's 8.3% CAGR performance relative to global trends (12% CAGR) to identify localized growth opportunities and market maturity levels specific to the Australian biopharmaceutical sector.
- CMO and Manufacturer Demand Analysis : Access detailed insights into Australian biopharmaceutical manufacturers and CMOs driving single-use bioreactor adoption, enabling targeted market entry and partnership strategies.
- Competitive Landscape for Australia : Gain intelligence on key players, market consolidation trends, and competitive dynamics specific to Australia to inform product development, pricing, and distribution strategies.
- Regulatory and Operational Context : Understand Australia-specific regulatory frameworks, manufacturing standards, and operational preferences influencing single-use bioreactor adoption to ensure compliant market strategies.
Frequently asked questions
What is the current market size of single-use bioreactors in Australia?
Australia's single-use bioreactors market is valued at USD 22.4 million in 2026 and is expected to grow to USD 33.4 million by 2031.
What is the projected growth rate for Australia's single-use bioreactors market?
Australia's single-use bioreactors market is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2031.
Which industries in Australia are driving single-use bioreactor adoption?
Australia's biopharmaceutical manufacturers, contract manufacturing organizations (CMOs), and vaccine producers are the primary drivers of single-use bioreactor adoption.
What are the key applications of single-use bioreactors in Australia?
In Australia, single-use bioreactors are primarily used for vaccine production, monoclonal antibody manufacturing, and cell therapy applications.
Why is Australia's market growing slower than the global average?
Australia's 8.3% CAGR reflects the country's mature but smaller market size compared to global trends; however, Australia benefits from strong regulatory frameworks and established life sciences infrastructure supporting sustainable growth.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
